5,N,N-TMT

5,N,N-TMT

Identifiers
IUPAC name (2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
CAS Number	22120-39-4 Y
PubChem CID	1837
ChemSpider	1771 Y
UNII	HIX0SK1CCX
CompTox Dashboard (EPA)	DTXSID30176641
ECHA InfoCard	100.164.424
Chemical and physical data
Formula	C13H18N2
Molar mass	202.301 g·mol−1
3D model (JSmol)	Interactive image
SMILES c1c(ccc2c1c(c[nH]2)CCN(C)C)C
InChI InChI=1S/C13H18N2/c1-10-4-5-13-12(8-10)11(9-14-13)6-7-15(2)3/h4-5,8-9,14H,6-7H2,1-3H3 Y Key:NCGJLYBZSJSCIC-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a psychedelic drug. It was first made in 1958 by E. H. Young. In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency which would suggest an active dosage for humans in the 20–60 mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.

Legal Status

United States

5,N,N-TMT is not scheduled at the federal level in the United States, but it could be considered an analog of 5-MeO-DMT, in which case, sales or possession intended for human consumption could be prosecuted under the Federal Analog Act.

See also

• 2,N,N-TMT
• 7,N,N-TMT
• 5-Chloro-DMT
• 5-Ethyl-DMT